Riskpilot← Back to searchSign inGet full accessINTER-MEDICAL AS
ASActiveOrg 955308042Balders Veg 3, 2816 GjøvikWholesale of pharmaceutical and medical goods · NACE 4646Est. 19898 employees
Revenue 2024
NOK 44,9M
0% vs 2023
EBITDA margin
8.6%
-11% vs 2023
Equity ratio
33.9%
Financial strength
Net profit 2024
NOK 2,6M
-19% vs 2023
| Revenue | NOK 44,9M | +0% |
| EBITDA | NOK 3,9M | -11% |
| Net profit | NOK 2,6M | -19% |
| Total assets | NOK 22,2M | +15% |
| Equity | NOK 7,5M | +22% |
| Employees | 8 | — |
Legal name
INTER-MEDICAL AS
Org number
955308042
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3. juli 1989
Share capital
—
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Handelsvirksomhet innen medisinske instrumenter/apparater, samt det som naturlig står i forbindelse med dette. Selskapet kan også delta i andre selskaper innen samme eller beslektede bransjer.
Address
Balders Veg 3, 2816 Gjøvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 31 045 | 30 652 | 48 631 | 45 070 | 44 933 |
| Staff expenses | −4 863 | −6 496 | −7 237 | −7 039 | −7 182 |
| EBITDA | 3 620 | 953 | 3 871 | 4 337 | 3 861 |
| Depreciation & amort. | −32 | −47 | −47 | −166 | −409 |
| EBIT | 3 588 | 905 | 3 823 | 4 172 | 3 453 |
| Net financials | −580 | 4 | −44 | −63 | −230 |
| Profit before tax | 3 008 | 909 | 3 780 | 4 108 | 3 223 |
| Tax | 633 | 229 | 896 | 954 | 667 |
| Net profit | 2 374 | 680 | 2 884 | 3 154 | 2 556 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 13 616 | 12 643 | 24 485 | 19 289 | 22 179 |
| Equity | 3 439 | 4 119 | 5 003 | 6 157 | 7 512 |
| Long-term debt | 900 | 900 | 900 | 900 | 900 |
| Short-term debt | 9 277 | 7 625 | 18 582 | 12 232 | 13 766 |
| Total debt | 10 177 | 8 525 | 19 482 | 13 132 | 14 666 |
EBITDA margin
8.6%
This company
15.8%
Market median
-46% vs market
20202024
Equity ratio
33.9%
This company
38.2%
Market median
+11% vs market
20202024
Return on equity
34.0%
This company
18.4%
Market median
+85% vs market
20202024
Net profit margin
5.7%
This company
8.1%
Market median
-30% vs market
20202024
Asset turnover
2.03×
This company
1.12×
Market median
+81% vs market
20202024
Debt / equity
1.95×
This company
0.62×
Market median
-215% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EM Deputy Member | Deputy Member | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 51% | 51% | 2022 | |
| Individual | 18% | 18% | 2022 | |
| Individual | 18% | 18% | 2022 | |
| Company | 13% | 13% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
INTER-MEDICAL AS 
ALFA MEDICAL ASBoard members of INTER-MEDICAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Magne Sandvik | Deputy Member | 0 companies |
| Kjell Bjarne Robøle | Board of Directors | 0 companies |
| Finn Øystein Kristoffersen | Chairman | 0 companies |